ASRX is a biotech company seeking to find treatments and cures for ADNP Syndrome
Welcome to ASRX
OUR WEBSITE IS CURRENTLY UNDER CONSTRUCTION
Why ASRX?
AS stands for ADNP Syndrome, and also happens to be the initials of my sons name, Anthony Sermone. RX stands for the hopeful treatment we will find for ADNP Syndrome.
ASRX was formed solely to accelerate potential therapeutics for ADNP, with the hopes to move quickly toward successful and meaningful treatments and cures for ADNP Syndrome.
ADNP was discovered in 2014, there currently are approximately 300 diagnosed patients worldwide. ADNP is one of the top single gene causes of Autism and Neurodevelopmental disorders. Learn more at www.adnpfoundation.org.
There currently is not one single FDA approved treatment for ADNP Syndrome. Each day that goes buy is brain development lost, we simply cannot wait, we must find treatments!
“As a parent of a child with ADNP Syndrome, there is nothing that I wouldn’t do to help my son and others with ADNP Syndrome. I have urgency! Stopping the degenerative progression of his disease, giving him a better qualify of life, and helping others with ADNP Syndrome live life to their full potential, that is what motivates me”.
Sandra Bedrosian-Sermone, Founder
PATH FORWARD
Our approach is to collaborate with academic researchers to help them fund, move forward and commercialize their technologies for therapeutics targeting ADNP Syndrome.
OUR SITE IS CURRENTLY UNDER CONSTRUCTION
MORE TO COME…..
ABOUT ADNP SYNDROME
NEWS
Currently Under Construction
More to come….
TEAM
Thank you for your response. ✨
ASRX
Website currently under construction